Asp49 phospholipase A(2)-elaidoylamide complex: a new mode of inhibition

Biochem Biophys Res Commun. 2004 Jul 9;319(4):1314-21. doi: 10.1016/j.bbrc.2004.05.106.

Abstract

The inhibition of phospholipase A(2)s (PLA(2)s) is of pharmacological and therapeutic interest because these enzymes are involved in several inflammatory diseases. Elaidoylamide is a powerful inhibitor of a neurotoxic PLA(2) from the Vipera ammodytes meridionalis venom. The X-ray structure of the enzyme-inhibitor complex reveals a new mode of Asp49 PLA(2) inhibition by a fatty acid hydrocarbon chain. The structure contains two identical homodimers in the asymmetric unit. In each dimer one subunit is rotated by 180 degrees with respect to the other and the two molecules are oriented head-to-tail. One molecule of elaidoylamide is bound simultaneously to the substrate binding sites of two associated neurotoxic phospholipase A(2) molecules. The inhibitor binds symmetrically to the hydrophobic channels of the two monomers. The structure can be used to design anti-inflammatory drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides* / chemistry
  • Amides* / metabolism
  • Animals
  • Aspartic Acid / metabolism*
  • Crystallography, X-Ray
  • Dimerization
  • Enzyme Inhibitors* / chemistry
  • Enzyme Inhibitors* / metabolism
  • Macromolecular Substances
  • Models, Molecular
  • Molecular Structure
  • Neurotoxins / metabolism
  • Oleic Acid* / chemistry
  • Oleic Acid* / metabolism
  • Oleic Acids
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A / chemistry*
  • Phospholipases A / genetics
  • Phospholipases A / metabolism*
  • Protein Binding
  • Protein Conformation*
  • Protein Subunits / chemistry
  • Protein Subunits / metabolism
  • Viper Venoms / enzymology

Substances

  • Amides
  • Enzyme Inhibitors
  • Macromolecular Substances
  • Neurotoxins
  • Oleic Acids
  • Protein Subunits
  • Viper Venoms
  • Oleic Acid
  • Aspartic Acid
  • elaidic acid
  • Phospholipases A